<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32155148</PMID>
      <DateCompleted>
        <Year>2020</Year>
        <Month>05</Month>
        <Day>12</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>01</Month>
        <Day>10</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">1935-2735</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>14</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>PLoS neglected tropical diseases</Title>
          <ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Surveillance of Salmonella enterica serovar  Typhi in Colombia, 2012-2015.</ArticleTitle>
        <Pagination>
          <StartPage>e0008040</StartPage>
          <MedlinePgn>e0008040</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e0008040</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0008040</ELocationID>
        <Abstract>
          <AbstractText>Salmonella Typhi (S. Typhi) is the causative agent of typhoid fever; a systemic disease affecting ~20 million people per year globally. There are little data regarding the contemporary epidemiology of typhoid in Latin America. Consequently, we aimed to describe some recent epidemiological aspects of typhoid in Colombia using cases reported to the National Public Health Surveillance System (Sivigila) between 2012 and 2015. Over the four-year reporting period there were 836 culture confirmed cases of typhoid in Colombia, with the majority (676/836; 80.1%) of reported cases originated from only seven departments. We further characterized 402 S. Typhi isolates with available corresponding data recovered from various departments of Colombia through antimicrobial susceptibility testing and molecular subtyping. The majority (235/402; 58.5%) of these typhoid cases occurred in males and were most commonly reported in those aged between 10 and 29 years (218/402; 54.2%); there were three (0.74%) reported fatalities. The overwhelming preponderance (339/402; 84.3%) of S. Typhi were susceptible to all tested antimicrobials. The most common antimicrobial to which the organisms exhibited non-susceptibility was ampicillin (30/402;7.5%), followed by nalidixic acid (23/402, 5.7%). Molecular subtyping identified substantial genetic diversity, which was well distributed across the country. Despite the diffuse pattern of S. Typhi genotypes, we identified various geographical hotspots of disease associated with local dominant genotypes. Notably, we found limited overlap of Colombian genotypes with organisms reported in other Latin American countries. Our work highlights a substantial burden of typhoid in Colombia, characterized by sustained transmission in some regions and limited epidemics in other departments. The disease is widely distributed across the country and associated with multiple antimicrobial susceptible genotypes that appear to be restricted to Colombia. This study provides a current perspective for typhoid in Latin America and highlights the importance of pathogen-specific surveillance to add insight into the limited epidemiology of typhoid in this region.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Diaz-Guevara</LastName>
            <ForeName>Paula</ForeName>
            <Initials>P</Initials>
            <Identifier Source="ORCID">0000-0002-8252-5622</Identifier>
            <AffiliationInfo>
              <Affiliation>Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Montaño</LastName>
            <ForeName>Lucy Angeline</ForeName>
            <Initials>LA</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Duarte</LastName>
            <ForeName>Carolina</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zabaleta</LastName>
            <ForeName>Gabriela</ForeName>
            <Initials>G</Initials>
            <AffiliationInfo>
              <Affiliation>Grupo de Microbiología, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Maes</LastName>
            <ForeName>Mailis</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Cambridge Institute of Therapeutic Immunology &amp; Infectious Disease (CITIID), The University of Cambridge, Cambridge, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Martinez Angarita</LastName>
            <ForeName>Julio Cesar</ForeName>
            <Initials>JC</Initials>
            <AffiliationInfo>
              <Affiliation>Vigilancia y Análisis de Riesgo en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Thanh</LastName>
            <ForeName>Duy Pham</ForeName>
            <Initials>DP</Initials>
            <AffiliationInfo>
              <Affiliation>Oxford University Clinical Research Unit, The Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>León-Quevedo</LastName>
            <ForeName>William</ForeName>
            <Initials>W</Initials>
            <AffiliationInfo>
              <Affiliation>Observatorio Nacional de Salud, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Castañeda-Orjuela</LastName>
            <ForeName>Carlos</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Observatorio Nacional de Salud, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Alvarez Alvarez</LastName>
            <ForeName>Claudia Jimena</ForeName>
            <Initials>CJ</Initials>
            <AffiliationInfo>
              <Affiliation>Vigilancia y Análisis de Riesgo en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Guerrero</LastName>
            <ForeName>Jaime</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Vigilancia y Análisis de Riesgo en Salud Pública, Instituto Nacional de Salud, Bogotá, Colombia.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Moroni</LastName>
            <ForeName>Miriam</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Red Pulsenet Latino América y el Caribe, Subregional, Instituto Carlos Malbran, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Campos</LastName>
            <ForeName>Josefina</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Red Pulsenet Latino América y el Caribe, Subregional, Instituto Carlos Malbran, Buenos Aires, Argentina.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pérez</LastName>
            <ForeName>Enrique</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Health Emergencies Department, Pan American Health Organization/World Health Organization, PAHO/WHO, Washington DC, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Baker</LastName>
            <ForeName>Stephen</ForeName>
            <Initials>S</Initials>
            <Identifier Source="ORCID">0000-0003-1308-5755</Identifier>
            <AffiliationInfo>
              <Affiliation>Cambridge Institute of Therapeutic Immunology &amp; Infectious Disease (CITIID), The University of Cambridge, Cambridge, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>001</GrantID>
            <Acronym>WHO_</Acronym>
            <Agency>World Health Organization</Agency>
            <Country>International</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>03</Month>
          <Day>10</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>PLoS Negl Trop Dis</MedlineTA>
        <NlmUniqueID>101291488</NlmUniqueID>
        <ISSNLinking>1935-2727</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017677" MajorTopicYN="N">Age Distribution</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D003105" MajorTopicYN="N" Type="Geographic">Colombia</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024881" MajorTopicYN="N">Drug Resistance, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D062665" MajorTopicYN="N">Epidemiological Monitoring</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014644" MajorTopicYN="N">Genetic Variation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008826" MajorTopicYN="N">Microbial Sensitivity Tests</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D058889" MajorTopicYN="N">Molecular Typing</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012485" MajorTopicYN="N">Salmonella typhi</DescriptorName>
          <QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName>
          <QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
          <QualifierName UI="Q000302" MajorTopicYN="Y">isolation &amp; purification</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D017678" MajorTopicYN="N">Sex Distribution</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014435" MajorTopicYN="N">Typhoid Fever</DescriptorName>
          <QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors have declared that no competing interests exist.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2019</Year>
          <Month>7</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>1</Month>
          <Day>9</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>20</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2020</Year>
          <Month>5</Month>
          <Day>13</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>3</Month>
          <Day>11</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32155148</ArticleId>
        <ArticleId IdType="pmc">PMC7083327</ArticleId>
        <ArticleId IdType="doi">10.1371/journal.pntd.0008040</ArticleId>
        <ArticleId IdType="pii">PNTD-D-19-01222</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Parry Christopher M. Hien T, Dougan G, N White FJ. Typhoid Fever. N Engl J Med. 2002;347.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">12456854</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gunn, John S,Marshall J,Baker S,Dongol S, Charles R RE. Gallbladder Persistence. Trends Microbiol. 2014;22: 648–655. 10.1016/j.tim.2014.06.007
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2014.06.007</ArticleId>
            <ArticleId IdType="pmc">PMC4252485</ArticleId>
            <ArticleId IdType="pubmed">25065707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mogasale V, Maskery B, Ochiai RL, Lee JS, Mogasale V V., Ramani E, et al.
Burden of typhoid fever in low-income and middle-income countries: A systematic, literature-based update with risk-factor adjustment. Lancet Glob Heal. Mogasale et al. Open Access article distributed under the terms of CC BY-NC-SA; 2014;2: e570–e580. 10.1016/S2214-109X(14)70301-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S2214-109X(14)70301-8</ArticleId>
            <ArticleId IdType="pubmed">25304633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crump JA, Luby SP, Mintz ED. The global burden of typhoid fever. Bull World Health Organ. 2004;82: 346–353. 10.1590/S0042-96862004000500008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/S0042-96862004000500008</ArticleId>
            <ArticleId IdType="pmc">PMC2622843</ArticleId>
            <ArticleId IdType="pubmed">15298225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Crump JA, Mintz ED. Global Trends in Typhoid and Paratyphoid Fever. Clin Infect Dis. 2010;50: 241–246. 10.1086/649541
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/649541</ArticleId>
            <ArticleId IdType="pmc">PMC2798017</ArticleId>
            <ArticleId IdType="pubmed">20014951</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Olarte J, Galindo E. Salmonella typhi resistant to chloramphenicol, ampicillin, and other antimicrobial agents: strains isolated during an extensive typhoid fever epidemic in Mexico. Antimicrob Agents Chemother. 1973;4: 597–601. 10.1128/aac.4.6.597
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/aac.4.6.597</ArticleId>
            <ArticleId IdType="pmc">PMC444603</ArticleId>
            <ArticleId IdType="pubmed">4602828</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wain J, Hoa NTT, Chinh NT, Vinh H, Everett MJ, Diep TS, et al.
Quinolone‐Resistant Salmonella typhi in Viet Nam: Molecular Basis of Resistance and Clinical Response to Treatment. Clin Infect Dis. 1997;25: 1404–1410. 10.1086/516128
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/516128</ArticleId>
            <ArticleId IdType="pubmed">9431387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong VK, Baker S, Pickard DJ, Parkhill J, Page AJ, Feasey NA, et al.
Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter-and intracontinental transmission events. Nat Genet. 2015; 10.1038/ng.3281
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ng.3281</ArticleId>
            <ArticleId IdType="pmc">PMC4921243</ArticleId>
            <ArticleId IdType="pubmed">25961941</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ernst CM, Slavetinsky CM, Kuhn CJ, Hauser SN, Nega JN, Mishra MN, et al.
Gain-of-function RESEARCH ARTICLE Molecular Biology and Physiology crossm. MbioAsmOrg. 2018;9: 1659–1677. 10.1128/mBio</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Instituto Nacional de Salud. Vigilancia y Análisis del Riesgo en Salud Pública. Protocolo de Vigilancia en Salud Pública. Fiebre Tifoidea y paratifoidea. 2017. http://www.ins.gov.co/buscador-eventos/ZIKA%20Lineamientos/PRO%20Fiebre%20Tifoidea.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Instituto Nacional de Salud. Informe final del evento fiebre tifoidea y paratifoidea,Colombia,2014. [Internet]. 2014. Available: http://www.ins.gov.co/buscador-eventos/Informesdeevento/Fiebre tifoidea y taratifoidea 2014.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Instituto Nacional de Salud. Informe final del evento fiebre tifoidea y paratifoidea,Colombia,2015. [Internet]. Available: http://www.ins.gov.co/buscador-eventos/Informesdeevento/Fiebre tifoidea y paratifoidea 2015.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Instituto Nacional de Salud. Informe del evento Fiebre tifoidea y paratifoidea,hasta el periodo epidemiológico XIII,Colombia, 2016. 2016.</Citation>
        </Reference>
        <Reference>
          <Citation>Instituto Nacional de Salud. Protocolo de vigilancia en salud pública, fiebre tifoidea y paratifoidea. [Internet]. Available: http://www.ins.gov.co/buscador-eventos/Lineamientos/PRO Fiebre Tifoidea.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Grimont P, Weill F-X. Collaborating centre for reference and research on Salmonella. Inst Pasteur, París. 2007; Available: http://www.scacm.org/free/Antigenic Formulae of the Salmonella Serovars 2007 9th edition.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Wayne P. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Fifth Informational Supplement [Internet]. Clinical and Laboratory Standards Institute. 2015. Available: http://shopping.netsuite.com/s.nl/c.1253739/it.A/id.1684/.f</Citation>
        </Reference>
        <Reference>
          <Citation>Monstein HJ, Östholm-Balkhed Å, Nilsson M V., Nilsson M, Dornbusch K, Nilsson LE. Multiplex PCR amplification assay for the detection of blaSHV, blaTEM and blaCTX-M genes in Enterobacteriaceae. Apmis. 2007;115: 1400–1408. 10.1111/j.1600-0463.2007.00722.x
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1600-0463.2007.00722.x</ArticleId>
            <ArticleId IdType="pubmed">18184411</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ribot EM, Fair MA, Gautom R, Cameron DN, Hunter SB, Swaminathan B, et al.
Standardization of Pulsed-Field Gel Electrophoresis Protocols for the Subtyping of Escherichia coli O157:H7, Salmonella, and Shigella for PulseNet. Foodborne Pathogens and Disease. 2006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16602980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ribot EM, Swaminathan B, Taskforce P. PulseNet USA: A Five-Year Update. Foodborne Pathog Dis. 2006;3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16602975</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Swaminathan B, Gerner-Smidt P, Ng L-K, Lukinmaa S, Kam K-M, Rolando S, et al.
Building PulseNet International: An Interconnected System of Laboratory Networks to Facilitate Timely Public Health Recognition and Response to Foodborne Disease Outbreaks and Emerging Foodborne Diseases. Foodborne Pathog Dis. 2006;3: 36–50. 10.1089/fpd.2006.3.36
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/fpd.2006.3.36</ArticleId>
            <ArticleId IdType="pubmed">16602978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gatrell AC, Bailey TC, Diggle PJ, Rowlingson BS, Gatrell AC, Bailey TC, et al.
Diggle_SpatialPPA. Trans Inst Br Geogr New Ser. 2009;21: 256–274.</Citation>
        </Reference>
        <Reference>
          <Citation>Osei FB, Duker AA. Spatial and demographic patterns of Cholera in Ashanti region—Ghana. Int J Health Geogr. 2008. 
August
12;7:44
10.1186/1476-072X-7-44
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/1476-072X-7-44</ArticleId>
            <ArticleId IdType="pmc">PMC2533654</ArticleId>
            <ArticleId IdType="pubmed">18700026</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chinen I, Campos J, Dorji T, Pérez Gutiérrez E. PulseNet Latin America and the Caribbean Network: Present and Future. Foodborne Pathog Dis. 2019;16: 489–497. 10.1089/fpd.2018.2587
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/fpd.2018.2587</ArticleId>
            <ArticleId IdType="pmc">PMC6653793</ArticleId>
            <ArticleId IdType="pubmed">31081688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breiman RF, Cosmas L, Njuguna H, Audi A, Olack B, Ochieng JB, et al.
Population-based incidence of typhoid fever in an urban informal settlement and a rural area in Kenya: Implications for typhoid vaccine use in Africa. PLoS One. 2012;7
10.1371/journal.pone.0029119
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0029119</ArticleId>
            <ArticleId IdType="pmc">PMC3261857</ArticleId>
            <ArticleId IdType="pubmed">22276105</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stanaway JD, Reiner RC, Blacker BF, Goldberg EM, Khalil IA, Troeger CE, et al.
The global burden of typhoid and paratyphoid fevers: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect Dis. 2019; 10.1016/S1473-3099(18)30685-6
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S1473-3099(18)30685-6</ArticleId>
            <ArticleId IdType="pmc">PMC6437314</ArticleId>
            <ArticleId IdType="pubmed">30792131</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Levine MM, Black RE, Clements M Lou, Sears S, Morris JG, Lanata C. Studies to Control Endemic Typhoid Fever in Chile. 1984; 74.</Citation>
        </Reference>
        <Reference>
          <Citation>Ministerio de Salud y Protección Social. Caracterización registro Especial de Prestadores de Servicios de Salud REPS -IPS. 2017; 114. Available: https://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/PES/caracterizacion-registro-especial-prestadores-reps.pdf</Citation>
        </Reference>
        <Reference>
          <Citation>Giedion U, Uribe MV. MarketWatch: Colombia’s Universal Health Insurance System. Health Aff. 2009;28: 853–863. 10.1377/hlthaff.28.3.853
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1377/hlthaff.28.3.853</ArticleId>
            <ArticleId IdType="pubmed">19414898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Baker S, Duy PT, Nga TVT, Dung TTN, Phat VV, Chau TT, et al.
Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure. Elife. 2013;2013: 1–17. 10.7554/eLife.01229.001</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.01229.001</ArticleId>
            <ArticleId IdType="pmc">PMC3857714</ArticleId>
            <ArticleId IdType="pubmed">24327559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gwinji G, Manangazira P, Glavintcheva I, Mutukwa-Gonese G, Bara W, Chimbaru A, et al.
Guidelines for the Management of Typhoid Fever. World Heal Organ. 2011;3: 2–39. 10.1542/peds.2012-1231</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2012-1231</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lutterloh E, Likaka A, Sejvar J, Manda R, Naiene J, Monroe SS, et al.
Multidrug-resistant typhoid fever with neurologic findings on the Malawi-Mozambique border. Clin Infect Dis. 2012;54: 1100–1106. 10.1093/cid/cis012
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cis012</ArticleId>
            <ArticleId IdType="pubmed">22357702</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>González-López JJ, Piedra-Carrasco N, Salvador F, Rodríguez V, Sánchez-Montalvá A, Planes AM, et al.
ESBL-producing salmonella enterica serovar typhi in traveler returning from guatemala to spain. Emerg Infect Dis. 2014;20: 1918–1920. 10.3201/eid2011.140525
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid2011.140525</ArticleId>
            <ArticleId IdType="pmc">PMC4214306</ArticleId>
            <ArticleId IdType="pubmed">25340972</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wong VK, Baker S, Connor TR, Pickard D, Page AJ, Dave J, et al.
An extended genotyping framework for Salmonella enterica serovar Typhi, the cause of human typhoid. Nat Commun. 2016;7
10.1038/ncomms12827
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms12827</ArticleId>
            <ArticleId IdType="pmc">PMC5059462</ArticleId>
            <ArticleId IdType="pubmed">27703135</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Instituto Nacional de Salud. Análisis de riesgo en salud pública en el marco del flujo migratorio. 2019.</Citation>
        </Reference>
        <Reference>
          <Citation>Baker S, Holt KE, Clements ACA, Karkey A, Arjyal A, Boni MF, et al.
Combined high-resolution genotyping and geospatial analysis reveals modes of endemic urban typhoid fever transmission. Open Biol. 2011;1
10.1098/rsob.110008
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1098/rsob.110008</ArticleId>
            <ArticleId IdType="pmc">PMC3352080</ArticleId>
            <ArticleId IdType="pubmed">22645647</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Campos J, Pichel M, Vaz TMI, Tavechio AT, Fernandes SA, Muñoz N, et al.
Building PulseNet Latin America and Caribbean Salmonella regional database: First conclusions of genetic subtypes of S. Typhi, S. Typhimurium and S. Enteritidis circulating in six countries of the region. Food Res Int. Elsevier Ltd; 2012;45: 1030–1036. 10.1016/j.foodres.2011.10.020</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.foodres.2011.10.020</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez EC, Díaz-Guevara P, Moreno J, Bautista A, Montaño L, Realpe ME, et al.
Vigilancia por laboratorio de Salmonella enterica en casos clínicos humanos en Colombia 2005 a 2011. Enferm Infecc Microbiol Clin. 2017; 10.1016/j.eimc.2016.02.023
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.eimc.2016.02.023</ArticleId>
            <ArticleId IdType="pubmed">27038678</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Salve A, Pichel M, Wiesner M, Hidalgo M, Terragno R, Álvarez A, et al.
Molecular Subtyping of Salmonella enterica Serovar Typhi Isolates from Colombia and Argentina. Foodborne Pathog Dis. 2006; 10.1089/fpd.2006.3.142
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/fpd.2006.3.142</ArticleId>
            <ArticleId IdType="pubmed">16602990</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>P Diaz,J Campos, M Moroni et al. Diversidad genética de subtipos por PFGE, susceptibilidad antimicrobiana y distribución geográfica de aislamientos endémicos de Salmonella Typhi en países de participantes de la Red Pulsenet Latinoamérica y el Caribe. Libro de resumenesXXIII Congreso Latinoamericano de MIicrobiología XIV Congreso Argentino de Microbiología IV Congreso Latinioamericano de Microbiología de Medicamentos–CLAMME Reunión de la sociedad Latinoamericana de Tuberculosis y otras Micobacterios. 2016. pp. 428–429. Available: http://www.alam-cam2016.aam.org.ar/descarga/LibroCAMALAM2016.pdf</Citation>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
